Inventor
ROBERT F. KELLEY
Inventor
US
Overview
Patents· 10 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
C07KPeptides30%
A61KPreparations for medical, dental or toiletry purposes21%
G01NInvestigating or analysing materials by determining their chemical or physical properties12%
C12NMicroorganisms or enzymes6%
PatentTitleYear
12,466,896Anti-CD3 antibodies and methods of use202512,286,470Methods of determining the function of polyubiquitin using anti-polyubiquitin antibodies202512,037,385Anti-polyubiquitin antibodies and methods of use202411,753,464Methods and compositions for targeting polyubiquitin202311,732,054Anti-CD3 antibodies and methods of use202311,597,761Methods of detecting polyubiquitin using anti-polyubiquitin antibodies202311,530,275Anti-CD3 antibodies and methods of use202211,512,143Anti-HtrA1 antibodies and methods of use thereof202211,466,087Anti-CLL-1 antibodies and methods of use202211,186,650Anti-CD3 antibodies and methods of use2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Patents assigned to GENENTECH INC (10)· patent assignee history
2021–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| GENENTECH INC | 10 | 2021–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 10 | 2021–2025 |